Registry of Lobbyists
Total Number of Communication Reports: 1
Monthly communication reports in the last 6 months: 0
Resilience Biotechnologies (RBI), formerly Therapure Biopharma, is a wholly owned subsidiary of National Resilience, Inc. RBI is an Ontario-based Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of complex biologics. RBI’s mission is to support for Canadian vaccine and therapeutics production and serve as a long-term partner for Canadian pharmaceutical manufacturing.
Sankalp Vashishtha, Vice President / General Manager
End date of the last completed financial year: 2022-12-31
| Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
|---|---|---|
| National Research Council (NRC) | $35,079.72 | No |
Address:
2585 Meadowpine Blvd.
Mississauga, ON L5N 8H9
Canada
Telephone number:
905-286-6200
Resilience Biotechnologies, Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking